Artra Group (TSE:6029) Debt-to-EBITDA : N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6029 Artra Group Corp TSE:6029
57 GF Score
Price 円185.00
GF Value 円115.85
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Artra Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Artra Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was 円158 Mil. Artra Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was 円585 Mil. Artra Group's annualized EBITDA for the quarter that ended in Jun. 2026 was 円0 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Artra Group's Debt-to-EBITDA or its related term are showing as below:

TSE:6029' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -14.89   Med: 2.21   Max: 18.65
Current: 2.77

During the past 13 years, the highest Debt-to-EBITDA Ratio of Artra Group was 18.65. The lowest was -14.89. And the median was 2.21.

TSE:6029's Debt-to-EBITDA is ranked worse than
57.95% of 478 companies
in the Healthcare Providers & Services industry
Industry Median: 2.185 vs TSE:6029: 2.77

Artra Group  (TSE:6029) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Artra Group Debt-to-EBITDA Related Terms

Artra Group Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Artra Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artra Group Debt-to-EBITDA Chart

Artra Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.89 10.01 6.73 8.71 2.92

Artra Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.49 21.76 1.62 -1.88 N/A

TSE:6029 vs HCA, THC, EHC: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Artra Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artra Group Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Artra Group's Debt-to-EBITDA falls into.


TSE:6029
57GF Score
Artra Group Corp TSE:6029
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artra Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Artra Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(217.895 + 832.947) / 360.547
=2.91

Artra Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(157.935 + 585.031) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is Artra Group (TSE:6029) Overvalued in 2026?

Based on GuruFocus' analysis, Artra Group stock appears to be overvalued. The current stock price of 円185.00 is trading 59.7% above its estimated GF Value™ of 円115.85. GuruFocus considers Artra Group to be Significantly Overvalued.

Key valuation signals for TSE:6029:

  • Debt-to-EBITDA: N/A
  • GF Value™: 円115.85 vs. price of 円185.00 (59.7% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Artra Group Business Description

Address 4-6-9 Tachimichibori, Taiga Building, Nishi-ku, Osaka, JPN, 550-0012
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
57GF Score

Get the complete analysis for TSE:6029

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円185.00
Price
円115.85
GF Value